Parker Foundation

Congrats to Mary Brunkow, Shimon Sakaguchi & PICI scientific advisor & former CSO Fred Ramsdell, for receiving the @NobelPrize for their work on peripheral immune tolerance. This recognition reinforces why deep study of the immune system remains central to scientific progress.

Join us in welcoming @DrKarenKnudsen as PICI's Chief Executive Officer! A visionary in oncology, healthcare delivery & nonprofit strategy, Dr. Knudsen embodies the values that define PICI: scientific rigor, bold thinking & a commitment to transformative patient impact. (1/3)

Could the body's own immune system defeat #cancer? Find out in the latest issue of @StanfordMed Magazine, with insights from #StanDOM's Edgar Engleman, Crystal Mackall, Ronald Levy, Matthew Frank & @DrBetofMDPhD! stan.md/3EiLS1L

NEW in @NatureMedicine: Results from a phase 3 clinical trial led by MSK's #myeloma specialist & cellular therapist @szusmani. Learn more: nature.com/articles/s4159…

With cancer research and care a top priority, Stanford Medicine’s leaders are charting a bold course to redefine how we understand, prevent and treat the disease. #WorldCancerDay @StanfordHealth @StanfordChild stanmed.stanford.edu/leaders-priori…

I-O breakthroughs at @UCLAHealth: Antoni Ribas, MD, PhD, Director of PICI Research Center at @UCLA, and @PuigSaus, PhD, PICI Investigator & 2020 Senior Parker Fellow, are developing novel precision treatments for challenging forms of malignant melanoma. uclahealth.org/news/article/n…

From Bench to Fireside is back! Join "the father of CAR T therapy" @carlhjune, Director of the PICI Center at @Penn, as he explores PICI's impact. From CAR T to future pioneers, don't miss his convo with PICI Chief Scientific Officer @John_E_Connolly. podcasts.apple.com/us/podcast/fro…

According to a new clinical trial led by researchers from @sheffielduni, survival rates for patients with operable bladder cancer are significantly improved by adding an immunotherapy drug to before and after surgery. More: bit.ly/4jrjri7 #BladderCancer #Immunotherapy

Discover how CRI Scientific Advisory Council member Dr. Antoni Ribas and his colleagues at @UCLAHealth have harnessed immunotherapy throughout the past decade to "change the war on malignant melanoma": bit.ly/3WjC6Td #Melanoma #Immunotherapy #CancerResearch

"Social drivers of health impact patients' ability to receive needed cancer screenings," shares senior author Dr. Gold. "It's very important to understand this, because cancer screenings save lives, and should be equitably accessible to all." bit.ly/49C6M7v #HealthEquity

A light-activated treatment for cutaneous T-cell #lymphoma—a rare, slow-growing type of non-Hodgkin lymphoma—shows promise, according to a clinical trial led by dermatologist Dr. Ellen Kim. The results have been “exciting to see,” she told @TargetedOnc. spr.ly/6011aIPfT

Cancer therapy’s new ‘gold rush’: bispecific antibodies that hit key combination of targets trib.al/CnJb1Ym

Researchers from @UCSF have identified a new type of stem cell "that helps young brains grow but is also capable of forming the cells found in tumors." Understand how this discovery could transform treatment strategies for glioblastoma: bit.ly/3C4bUFh #GBM #Glioblastoma

I was inspired by the discussion at the recent Global Cancer Fund Roundtable to address cancer inequalities that we see worldwide. Just as we strive to provide the highest quality care to every patient at Memorial Sloan Kettering, this fund represents a collective effort to ensure that people around the world have access to life-saving cancer treatments, regardless of their circumstances. I am honored to be a part of this global movement and believe that through collaboration and innovation, we can make a lasting impact on the lives of countless people affected by cancer. #GlobalCancerMoonshot

A group of immune proteins prevents blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, according to team led by Dr. Julie Magarian Blander of @WCMDeptofMed and @WCM_MeyerCancer. bit.ly/3E5m8Wg

Looking for a new job in 2025? Here are some opportunities open at Gladstone! ⭐ Postdoctoral Scholar- Hoffmann Lab: bit.ly/4gNBaP1 ☀️ Postdoctoral Scholar - Huang Lab: bit.ly/4hsWr0D Find more: gladstone.wd5.myworkdayjobs.com/en-US/careers #jobs #ScienceCareers #Postdocs

Understand the opportunities AI and machine learning are unlocking for the future of immunotherapy, with Dr. Elana Fertig of @JohnsHopkins! Watch the newest video in our Cancer Immunotherapy and You™ Patient Education webinar series now: bit.ly/4hR2H3b #Immunotherapy

New year, new episodes! PICI's podcast From Bench to Fireside is back later this month! Join our CSO @John_E_Connolly for conversations with i-o pioneers including @carlhjune, @EMittendorfMD, @RZappasodi, Toni Ribas & more. Catch up on episodes you missed: podcasts.apple.com/us/podcast/fro…

A new artificial intelligence tool developed at Stanford Medicine combines data from medical images with text to predict cancer prognoses and treatment responses. stan.md/4gN3S2x

Join leading experts and discover the latest advancements in cancer immunotherapy research, in our Cancer Immunotherapy and You™ Patient Education Webinar Series! Discover today: bit.ly/4dfCGrg #CancerResearch #Immunotherapy #CRIWebinar